Get Real Time Here
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Bicycle Therapeutics Stock (NASDAQ:BCYC), Quotes and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.170 | (EXPECTED) 2023-11-02 | |||||
| REV | 13.090M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.290 | -1.410 | -0.1200 | ||||
| REV | 4.580M | 11.397M | 6.817M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | B. Riley Securities | Kalpit Patel | Upgrades | NeutralBuy | Announces | - | 33.00 |
| 2023-09-12 | Cantor Fitzgerald | Li Watsek | Reiterates | OverweightOverweight | Maintains | - | 65.00 |
| 2023-09-12 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 44.00 |
| 2023-09-12 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 46.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCYC | Bicycle Therapeutics | -0.5% | 728.1M |
| VALN | Valneva | 17.28% | 922.9M |
| COGT | Cogent Biosciences | 0.42% | 819.6M |
| AMAM | Ambrx Biopharma | 3.76% | 719.3M |
| IMTX | Immatics | -3.71% | 835.3M |
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Who are Bicycle Therapeutics's (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Pharming (NASDAQ:PHAR).
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by B. Riley Securities on Tuesday, September 12, 2023. The analyst firm set a price target for 33.00 expecting BCYC to rise to within 12 months (a possible 66.41% upside). 27 analyst firms have reported ratings in the last year.
Current Stock Price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $19.83 last updated October 3, 2023 at 8:00 PM UTC.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There is no dividend information for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bicycle Therapeutics Stock (NASDAQ:BCYC), Quotes and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.170 | (EXPECTED) 2023-11-02 | |||||
| REV | 13.090M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.290 | -1.410 | -0.1200 | ||||
| REV | 4.580M | 11.397M | 6.817M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | B. Riley Securities | Kalpit Patel | Upgrades | NeutralBuy | Announces | - | 33.00 |
| 2023-09-12 | Cantor Fitzgerald | Li Watsek | Reiterates | OverweightOverweight | Maintains | - | 65.00 |
| 2023-09-12 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 44.00 |
| 2023-09-12 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 46.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCYC | Bicycle Therapeutics | -0.5% | 728.1M |
| VALN | Valneva | 17.28% | 922.9M |
| COGT | Cogent Biosciences | 0.42% | 819.6M |
| AMAM | Ambrx Biopharma | 3.76% | 719.3M |
| IMTX | Immatics | -3.71% | 835.3M |
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Who are Bicycle Therapeutics's (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Pharming (NASDAQ:PHAR).
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by B. Riley Securities on Tuesday, September 12, 2023. The analyst firm set a price target for 33.00 expecting BCYC to rise to within 12 months (a possible 66.41% upside). 27 analyst firms have reported ratings in the last year.
Current Stock Price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $19.83 last updated October 3, 2023 at 8:00 PM UTC.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There is no dividend information for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bicycle Therapeutics Stock (NASDAQ:BCYC), Quotes and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.170 | (EXPECTED) 2023-11-02 | |||||
| REV | 13.090M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.290 | -1.410 | -0.1200 | ||||
| REV | 4.580M | 11.397M | 6.817M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | B. Riley Securities | Kalpit Patel | Upgrades | NeutralBuy | Announces | - | 33.00 |
| 2023-09-12 | Cantor Fitzgerald | Li Watsek | Reiterates | OverweightOverweight | Maintains | - | 65.00 |
| 2023-09-12 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 44.00 |
| 2023-09-12 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 46.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCYC | Bicycle Therapeutics | -0.5% | 728.1M |
| VALN | Valneva | 17.28% | 922.9M |
| COGT | Cogent Biosciences | 0.42% | 819.6M |
| AMAM | Ambrx Biopharma | 3.76% | 719.3M |
| IMTX | Immatics | -3.71% | 835.3M |
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Who are Bicycle Therapeutics's (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Pharming (NASDAQ:PHAR).
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by B. Riley Securities on Tuesday, September 12, 2023. The analyst firm set a price target for 33.00 expecting BCYC to rise to within 12 months (a possible 66.41% upside). 27 analyst firms have reported ratings in the last year.
Current Stock Price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $19.83 last updated October 3, 2023 at 8:00 PM UTC.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There is no dividend information for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bicycle Therapeutics Stock (NASDAQ:BCYC), Quotes and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.170 | (EXPECTED) 2023-11-02 | |||||
| REV | 13.090M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.290 | -1.410 | -0.1200 | ||||
| REV | 4.580M | 11.397M | 6.817M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | B. Riley Securities | Kalpit Patel | Upgrades | NeutralBuy | Announces | - | 33.00 |
| 2023-09-12 | Cantor Fitzgerald | Li Watsek | Reiterates | OverweightOverweight | Maintains | - | 65.00 |
| 2023-09-12 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 44.00 |
| 2023-09-12 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 46.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCYC | Bicycle Therapeutics | -0.5% | 728.1M |
| VALN | Valneva | 17.28% | 922.9M |
| COGT | Cogent Biosciences | 0.42% | 819.6M |
| AMAM | Ambrx Biopharma | 3.76% | 719.3M |
| IMTX | Immatics | -3.71% | 835.3M |
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Who are Bicycle Therapeutics's (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Pharming (NASDAQ:PHAR).
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by B. Riley Securities on Tuesday, September 12, 2023. The analyst firm set a price target for 33.00 expecting BCYC to rise to within 12 months (a possible 66.41% upside). 27 analyst firms have reported ratings in the last year.
Current Stock Price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $19.83 last updated October 3, 2023 at 8:00 PM UTC.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There is no dividend information for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bicycle Therapeutics Stock (NASDAQ:BCYC), Quotes and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.170 | (EXPECTED) 2023-11-02 | |||||
| REV | 13.090M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.290 | -1.410 | -0.1200 | ||||
| REV | 4.580M | 11.397M | 6.817M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | B. Riley Securities | Kalpit Patel | Upgrades | NeutralBuy | Announces | - | 33.00 |
| 2023-09-12 | Cantor Fitzgerald | Li Watsek | Reiterates | OverweightOverweight | Maintains | - | 65.00 |
| 2023-09-12 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 44.00 |
| 2023-09-12 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 46.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCYC | Bicycle Therapeutics | -0.5% | 728.1M |
| VALN | Valneva | 17.28% | 922.9M |
| COGT | Cogent Biosciences | 0.42% | 819.6M |
| AMAM | Ambrx Biopharma | 3.76% | 719.3M |
| IMTX | Immatics | -3.71% | 835.3M |
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Who are Bicycle Therapeutics's (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Pharming (NASDAQ:PHAR).
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by B. Riley Securities on Tuesday, September 12, 2023. The analyst firm set a price target for 33.00 expecting BCYC to rise to within 12 months (a possible 66.41% upside). 27 analyst firms have reported ratings in the last year.
Current Stock Price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $19.83 last updated October 3, 2023 at 8:00 PM UTC.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There is no dividend information for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bicycle Therapeutics Stock (NASDAQ:BCYC), Quotes and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.170 | (EXPECTED) 2023-11-02 | |||||
| REV | 13.090M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.290 | -1.410 | -0.1200 | ||||
| REV | 4.580M | 11.397M | 6.817M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | B. Riley Securities | Kalpit Patel | Upgrades | NeutralBuy | Announces | - | 33.00 |
| 2023-09-12 | Cantor Fitzgerald | Li Watsek | Reiterates | OverweightOverweight | Maintains | - | 65.00 |
| 2023-09-12 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 44.00 |
| 2023-09-12 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 46.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCYC | Bicycle Therapeutics | -0.5% | 728.1M |
| VALN | Valneva | 17.28% | 922.9M |
| COGT | Cogent Biosciences | 0.42% | 819.6M |
| AMAM | Ambrx Biopharma | 3.76% | 719.3M |
| IMTX | Immatics | -3.71% | 835.3M |
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Who are Bicycle Therapeutics's (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Pharming (NASDAQ:PHAR).
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by B. Riley Securities on Tuesday, September 12, 2023. The analyst firm set a price target for 33.00 expecting BCYC to rise to within 12 months (a possible 66.41% upside). 27 analyst firms have reported ratings in the last year.
Current Stock Price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $19.83 last updated October 3, 2023 at 8:00 PM UTC.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There is no dividend information for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bicycle Therapeutics Stock (NASDAQ:BCYC), Quotes and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.170 | (EXPECTED) 2023-11-02 | |||||
| REV | 13.090M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.290 | -1.410 | -0.1200 | ||||
| REV | 4.580M | 11.397M | 6.817M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | B. Riley Securities | Kalpit Patel | Upgrades | NeutralBuy | Announces | - | 33.00 |
| 2023-09-12 | Cantor Fitzgerald | Li Watsek | Reiterates | OverweightOverweight | Maintains | - | 65.00 |
| 2023-09-12 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 44.00 |
| 2023-09-12 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 46.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCYC | Bicycle Therapeutics | -0.5% | 728.1M |
| VALN | Valneva | 17.28% | 922.9M |
| COGT | Cogent Biosciences | 0.42% | 819.6M |
| AMAM | Ambrx Biopharma | 3.76% | 719.3M |
| IMTX | Immatics | -3.71% | 835.3M |
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Who are Bicycle Therapeutics's (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Pharming (NASDAQ:PHAR).
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by B. Riley Securities on Tuesday, September 12, 2023. The analyst firm set a price target for 33.00 expecting BCYC to rise to within 12 months (a possible 66.41% upside). 27 analyst firms have reported ratings in the last year.
Current Stock Price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $19.83 last updated October 3, 2023 at 8:00 PM UTC.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There is no dividend information for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bicycle Therapeutics Stock (NASDAQ:BCYC), Quotes and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.170 | (EXPECTED) 2023-11-02 | |||||
| REV | 13.090M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.290 | -1.410 | -0.1200 | ||||
| REV | 4.580M | 11.397M | 6.817M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | B. Riley Securities | Kalpit Patel | Upgrades | NeutralBuy | Announces | - | 33.00 |
| 2023-09-12 | Cantor Fitzgerald | Li Watsek | Reiterates | OverweightOverweight | Maintains | - | 65.00 |
| 2023-09-12 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 44.00 |
| 2023-09-12 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 46.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCYC | Bicycle Therapeutics | -0.5% | 728.1M |
| VALN | Valneva | 17.28% | 922.9M |
| COGT | Cogent Biosciences | 0.42% | 819.6M |
| AMAM | Ambrx Biopharma | 3.76% | 719.3M |
| IMTX | Immatics | -3.71% | 835.3M |
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Who are Bicycle Therapeutics's (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Pharming (NASDAQ:PHAR).
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by B. Riley Securities on Tuesday, September 12, 2023. The analyst firm set a price target for 33.00 expecting BCYC to rise to within 12 months (a possible 66.41% upside). 27 analyst firms have reported ratings in the last year.
Current Stock Price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $19.83 last updated October 3, 2023 at 8:00 PM UTC.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There is no dividend information for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Bicycle Therapeutics Stock (NASDAQ:BCYC), Quotes and News Summary
Bicycle Therapeutics Stock (NASDAQ: BCYC) stock price, news, charts, stock research, profile.
| Open19.880 | Close19.830 |
| Vol / Avg.356.639K / 329.373K | Mkt Cap728.055M |
| Day Range19.600 - 20.120 | 52 Wk Range18.840 - 33.400 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.170 | (EXPECTED) 2023-11-02 | |||||
| REV | 13.090M | ||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.290 | -1.410 | -0.1200 | ||||
| REV | 4.580M | 11.397M | 6.817M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-12 | B. Riley Securities | Kalpit Patel | Upgrades | NeutralBuy | Announces | - | 33.00 |
| 2023-09-12 | Cantor Fitzgerald | Li Watsek | Reiterates | OverweightOverweight | Maintains | - | 65.00 |
| 2023-09-12 | JMP Securities | Reni Benjamin | Reiterates | Market OutperformMarket Outperform | Maintains | - | 44.00 |
| 2023-09-12 | Needham | Ami Fadia | Reiterates | BuyBuy | Maintains | - | 46.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| BCYC | Bicycle Therapeutics | -0.5% | 728.1M |
| VALN | Valneva | 17.28% | 922.9M |
| COGT | Cogent Biosciences | 0.42% | 819.6M |
| AMAM | Ambrx Biopharma | 3.76% | 719.3M |
| IMTX | Immatics | -3.71% | 835.3M |
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ: BCYC) through any online brokerage.
Who are Bicycle Therapeutics's (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Pharming (NASDAQ:PHAR).
What is the target price for Bicycle Therapeutics (BCYC) stock?
The latest price target for Bicycle Therapeutics (NASDAQ: BCYC) was reported by B. Riley Securities on Tuesday, September 12, 2023. The analyst firm set a price target for 33.00 expecting BCYC to rise to within 12 months (a possible 66.41% upside). 27 analyst firms have reported ratings in the last year.
Current Stock Price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $19.83 last updated October 3, 2023 at 8:00 PM UTC.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There is no dividend information for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.